209 related articles for article (PubMed ID: 9676763)
1. Reduced priming effect of interleukin 3 on IgE mediated basophil histamine release in patients with systemic sclerosis.
Tedeschi A; Salmaso C; Milazzo N; Miadonna A
J Rheumatol; 1998 Jul; 25(7):1320-4. PubMed ID: 9676763
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of basophil histamine release by interleukin-3: reduced effect in atopic subjects.
Miadonna A; Salmaso C; Cottini M; Milazzo N; Tedeschi A
Allergy; 1996 Aug; 51(8):525-31. PubMed ID: 8874655
[TBL] [Abstract][Full Text] [Related]
3. Impairment of the inhibitory effect of sodium on basophil histamine release in patients with systemic sclerosis.
Tedeschi A; Palella M; Milazzo N; Mascagni B; Miadonna A
Clin Exp Immunol; 1996 Apr; 104(1):97-102. PubMed ID: 8603541
[TBL] [Abstract][Full Text] [Related]
4. Comparison of mechanisms of IL-3 induced histamine release and IL-3 priming effect on human basophils.
Okayama Y; Begishvili TB; Church MK
Clin Exp Allergy; 1993 Nov; 23(11):901-10. PubMed ID: 10779277
[TBL] [Abstract][Full Text] [Related]
5. IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures.
Schroeder JT; MacGlashan DW; Kagey-Sobotka A; White JM; Lichtenstein LM
J Immunol; 1994 Aug; 153(4):1808-17. PubMed ID: 7519213
[TBL] [Abstract][Full Text] [Related]
6. The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.
Kurimoto Y; De Weck AL; Dahinden CA
Eur J Immunol; 1991 Feb; 21(2):361-8. PubMed ID: 1705512
[TBL] [Abstract][Full Text] [Related]
7. Analyzing histamine release by flow cytometry (HistaFlow): a novel instrument to study the degranulation patterns of basophils.
Ebo DG; Bridts CH; Mertens CH; Hagendorens MM; Stevens WJ; De Clerck LS
J Immunol Methods; 2012 Jan; 375(1-2):30-8. PubMed ID: 21945198
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.
Knol EF; Koenderman L; Mul FP; Verhoeven AJ; Roos D
Eur J Immunol; 1991 Apr; 21(4):881-5. PubMed ID: 1708341
[TBL] [Abstract][Full Text] [Related]
9. Effects of protein kinase C and phospholipase C inhibitors on IgE-dependent and IgE-independent basophil histamine release.
Tedeschi A; Lorini M; Gibelli S; Miadonna A
Inflamm Res; 2000 Sep; 49(9):480-5. PubMed ID: 11071123
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
Brunner T; de Weck AL; Dahinden CA
J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
[TBL] [Abstract][Full Text] [Related]
11. Defective inhibition of sodium on basophil histamine release in patients with allergic rhinitis and bronchial asthma.
Tedeschi A; Cottini M; Salmaso C; Milazzo N; Miadonna A
Eur Respir J; 1996 Oct; 9(10):2070-6. PubMed ID: 8902469
[TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin 2 on basophil histamine release.
Morita Y; Goto M; Miyamoto T
Allergy; 1987 Feb; 42(2):104-8. PubMed ID: 2438959
[TBL] [Abstract][Full Text] [Related]
13. Modulation of human basophil histamine release by hemopoietic growth factors.
Hirai K; Morita Y; Misaki Y; Ohta K; Takaishi T; Suzuki S; Motoyoshi K; Miyamoto T
J Immunol; 1988 Dec; 141(11):3958-64. PubMed ID: 2460553
[TBL] [Abstract][Full Text] [Related]
14. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus.
Lourenço FD; Azor MH; Santos JC; Prearo E; Maruta CW; Rivitti EA; Duarte AJ; Sato MN
Br J Dermatol; 2008 May; 158(5):979-86. PubMed ID: 18341658
[TBL] [Abstract][Full Text] [Related]
15. IFN-alpha inhibits IL-3 priming of human basophil cytokine secretion but not leukotriene C4 and histamine release.
Chen YH; Bieneman AP; Creticos PS; Chichester KL; Schroeder JT
J Allergy Clin Immunol; 2003 Nov; 112(5):944-50. PubMed ID: 14610485
[TBL] [Abstract][Full Text] [Related]
16. In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils.
Casolaro V; Spadaro G; Patella V; Marone G
J Immunol; 1993 Nov; 151(10):5563-73. PubMed ID: 7693814
[TBL] [Abstract][Full Text] [Related]
17. The in vitro and in vivo effect of corticosteroids on basophil releasability in patients with mild and severe bronchial asthma.
Kivity S; Onn A; Agami O; Fireman E
Clin Exp Allergy; 1997 Aug; 27(8):909-14. PubMed ID: 9291288
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release by a common pathway: downregulation by sodium.
Tedeschi A; Salmaso C; Di Donato M; Lorini M; Miadonna A
Immunology; 1999 Feb; 96(2):164-70. PubMed ID: 10233691
[TBL] [Abstract][Full Text] [Related]
19. Differential effect of hypertonicity on FMLP-, anti-IgE- and Ca2+ ionophore A23187-induced histamine release from human basophil leukocytes.
Tedeschi A; Arquati M; Lorini M; Miadonna A
Int Arch Allergy Appl Immunol; 1990; 93(4):359-64. PubMed ID: 1713571
[TBL] [Abstract][Full Text] [Related]
20. Priming and inducing effects of interleukin-3 on histamine release from cord-blood basophils.
Miadonna A; Salmaso C; Marco MP; Pugni L; Milazzo N; Tedeschi A; Marini A
Allergy; 1997 Oct; 52(10):992-8. PubMed ID: 9360750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
